U2AF2 and PUF60 mutations in cancer cells are less restricted than those in SF3B1 or U2AF1 [1]; nevertheless, a previous study mapped recurrent mutations to U2AF65-RNA interfaces [15]. This evidence concerns the gene U2AF2 and cancer.